These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunity to Respiratory Infection Is Reinforced Through Early Proliferation of Lymphoid T Suarez-Ramirez JE; Chandiran K; Brocke S; Cauley LS Front Immunol; 2019; 10():1370. PubMed ID: 31258537 [TBL] [Abstract][Full Text] [Related]
6. A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus. Lee YN; Lee YT; Kim MC; Gewirtz AT; Kang SM J Immunol; 2016 Mar; 196(6):2637-45. PubMed ID: 26864033 [TBL] [Abstract][Full Text] [Related]
7. Progesterone-Based Contraceptives Reduce Adaptive Immune Responses and Protection against Sequential Influenza A Virus Infections. Hall OJ; Nachbagauer R; Vermillion MS; Fink AL; Phuong V; Krammer F; Klein SL J Virol; 2017 Apr; 91(8):. PubMed ID: 28179523 [TBL] [Abstract][Full Text] [Related]
8. Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination. Hemann EA; Kang SM; Legge KL J Immunol; 2013 Sep; 191(5):2486-94. PubMed ID: 23885108 [TBL] [Abstract][Full Text] [Related]
9. Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections. Zacharias ZR; Ross KA; Hornick EE; Goodman JT; Narasimhan B; Waldschmidt TJ; Legge KL Front Immunol; 2018; 9():1953. PubMed ID: 30233573 [TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid Dendritic Cells Require Direct Infection To Sustain the Pulmonary Influenza A Virus-Specific CD8 T Cell Response. Hemann EA; Sjaastad LE; Langlois RA; Legge KL J Virol; 2015 Dec; 90(6):2830-7. PubMed ID: 26719269 [TBL] [Abstract][Full Text] [Related]
11. Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model. Dhakal S; Loube J; Misplon JA; Lo CY; Creisher PS; Mulka KR; Deshpande S; Mitzner W; Klein SL; Epstein SL J Virol; 2021 Apr; 95(9):. PubMed ID: 33627390 [TBL] [Abstract][Full Text] [Related]
12. Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in the local pulmonary tissue. Baaten BJ; Clarke B; Strong P; Hou S Vaccine; 2010 Jun; 28(25):4130-7. PubMed ID: 20433805 [TBL] [Abstract][Full Text] [Related]
13. Respiratory vaccination of mice against influenza virus: dissection of T- and B-cell priming functions. Coleclough C; Sealy R; Surman S; Marshall DR; Hurwitz JL Scand J Immunol; 2005 Jul; 62 Suppl 1():73-83. PubMed ID: 15953188 [TBL] [Abstract][Full Text] [Related]
14. Memory regulatory T cells home to the lung and control influenza A virus infection. Lu C; Zanker D; Lock P; Jiang X; Deng J; Duan M; Liu C; Faou P; Hickey MJ; Chen W Immunol Cell Biol; 2019 Oct; 97(9):774-786. PubMed ID: 31116465 [TBL] [Abstract][Full Text] [Related]
15. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010 [TBL] [Abstract][Full Text] [Related]
16. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin. Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221 [TBL] [Abstract][Full Text] [Related]
17. FcRn-Targeted Mucosal Vaccination against Influenza Virus Infection. Ochsner SP; Li W; Rajendrakumar AM; Palaniyandi S; Acharya G; Liu X; Wang G; Krammer F; Shi M; Tuo W; Pauza CD; Zhu X J Immunol; 2021 Sep; 207(5):1310-1321. PubMed ID: 34380652 [TBL] [Abstract][Full Text] [Related]
18. Analysis of different DNA vaccines for protection of experimental influenza A virus infection. Wiesener N; Schütze T; Lapp S; Lehmann M; Jarasch-Althof N; Wutzler P; Henke A Viral Immunol; 2011 Aug; 24(4):321-30. PubMed ID: 21830903 [TBL] [Abstract][Full Text] [Related]
19. Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice. Tan AC; Mifsud EJ; Zeng W; Edenborough K; McVernon J; Brown LE; Jackson DC Mol Pharm; 2012 Sep; 9(9):2710-8. PubMed ID: 22823162 [TBL] [Abstract][Full Text] [Related]
20. Intrinsic 4-1BB signals are indispensable for the establishment of an influenza-specific tissue-resident memory CD8 T-cell population in the lung. Zhou AC; Wagar LE; Wortzman ME; Watts TH Mucosal Immunol; 2017 Sep; 10(5):1294-1309. PubMed ID: 28051085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]